Skip to main content
Equibles

PLATINUM INVESTMENT MANAGEMENT LTD

Position in ZYME — Zymeworks Inc.

CIK 1256071 SYDNEY AUSTRALIA 2000, C3
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,749,509
+$115,702 QoQ
Shares Held
105,184
0.0% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#55
of 202 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PLATINUM INVESTMENT MANAGEMENT LTD holds $78,056,040 across 25 Biotechnology names. ZYME ranks #15 (3.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1
58,314 $7,740,017
2 COGT
Cogent Biosciences, Inc.
 154,220 $5,968,314
3 IMVT
Immunovant, Inc.
 144,671 $5,574,173
4 ARWR
Arrowhead Pharmaceuticals, Inc.
 64,752 $5,277,935
5 IDYA
IDEAYA Biosciences, Inc.
 138,708 $5,169,647
6 VERA
Vera Therapeutics, Inc.
 113,687 $4,878,309
7 GPCR
Structure Therapeutics Inc.
 90,363 $4,849,782
8 RCUS
Arcus Biosciences, Inc.
 134,217 $4,137,910

All Filings in ZYME

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,749,509 105,184
2026-03-31 $2,633,807 105,184
2025-12-31 $2,769,494 105,184
2025-09-30 $2,131,310 124,784
2025-06-30 $2,991,807 238,391
2025-03-31 $3,318,816 278,658
2024-12-31 $4,486,574 306,460
2024-09-30 $4,110,401 327,522
2024-06-30 $3,174,247 373,002
2024-03-31 $4,401,315 418,376
2023-12-31 $4,258,227 409,839
2023-09-30 $2,598,379 409,839
2023-06-30 $3,541,008 409,839
2023-03-31 $3,673,196 406,327
2022-12-31 $3,111,931 395,920